CENTRE FOR ADDICTION AND MENTAL HEALTH
Patent Owner
Stats
- 24 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Aug 10, 2017 most recent publication
Details
- 24 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 123 Total Citation Count
- Jan 31, 2002 Earliest Filing
- 25 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0073,755 Compositions and Methods for the Treatment and Prevention of Antipsychotic Medication-Induced Weight GainFeb 27, 15Mar 16, 17[A61K, C12Q, G06F]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9708385 Nucleic acids encoding polypeptides which disrupt D1-D2 dopamine receptor coupling and modulate functionJan 15, 16Jul 18, 17[A61K, C07K]
9670544 CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the sameJun 29, 15Jun 06, 17[C12Q, C12N, G01N, C07K]
9617320 Nucleic acids encoding FHL1 mutations associated with novel X-linked muscular myopathies and methods of screening a subjectAug 26, 15Apr 11, 17[C12Q, G01N, C07K]
9266954 Methods for modulating D1-D2 dopamine receptor coupling and functionApr 12, 13Feb 23, 16[A61K, C07K]
9150923 Methods of identifying FHL1 mutations associated with novel X-linked muscular myopathiesNov 12, 13Oct 06, 15[C12Q, G01N, C07K]
9096903 CC2D2A gene mutations associated with Joubert syndrome and diagnostic methods for identifying the sameDec 02, 13Aug 04, 15[C12Q, C07K]
8716444 Method and apparatus for predicting susceptibility to a developmental disorderMar 26, 10May 06, 14[C12Q, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0315,640 IDENTIFICATION OF THE DCPS GENE ON 11Q24.2, WHICH ENCODES THE HUMAN DECAPPING ENZYME SCAVENGER, IN NON-SYNDROMIC AUTOSOMAL RECESSIVE MENTAL RETARDATION, DIAGNOSTIC PROBES THEREOF AND METHODS OF IDENTIFYING SUBJECTS WITH SAMEAbandonedNov 07, 13Nov 05, 15[C12Q, C12N, G01N]
2015/0141,287 GENETIC MARKERS ASSOCIATED WITH INTELLECTUAL DISABILITYAbandonedJan 22, 15May 21, 15[C12Q, C12N, C07K]
2015/0118,687 METHOD AND APPARATUS FOR PREDICTING SUSCEPTIBILITY TO A DEVELOPMENTAL DISORDERAbandonedJan 09, 15Apr 30, 15[C12Q]
2014/0227,696 METHOD AND APPARATUS FOR PREDICTING SUSCEPTIBILITY TO A DEVELOPMENTAL DISORDERAbandonedMar 21, 14Aug 14, 14[C12Q]
2014/0038,840 DNA Methylation Changes Associated with Major PsychosisAbandonedAug 02, 13Feb 06, 14[C12Q]
2013/0345,122 COMPOSITIONS AND METHODS FOR MODULATING DOPAMINE NEUROTRANSMISSIONAbandonedAug 14, 13Dec 26, 13[C07K]
8552152 Compositions and methods for modulating dopamine neurotransmissionExpiredOct 05, 12Oct 08, 13[A61K, A61B, C07K]
2013/0116,149 Genetic Markers Associated with Intellectual DisabilityAbandonedJun 23, 11May 09, 13[C12Q]
8304519 Compositions and methods for modulating dopamine neurotransmissionExpiredOct 14, 10Nov 06, 12[A61K, C07K]
2012/0220,475 DNA Methylation Changes Associated with Major PsychosisAbandonedDec 27, 11Aug 30, 12[C40B]
2012/0208,711 Method for Analysis of DNA Methylation Profiles of Cell-Free Circulating DNA in Bodily FluidsAbandonedOct 01, 10Aug 16, 12[C40B]
2011/0097,324 COMPOSITIONS AND METHODS FOR MODULATING NICOTINIC/NMDA RECEPTOR FUNCTIONAbandonedJun 15, 09Apr 28, 11[A61K, C07H, C12N, A61P, C07K]
2010/0234,242 DNA Methylation Changes Associated with Major PsychosisAbandonedJan 23, 08Sep 16, 10[C07H, C12Q, C07D, C40B]
2008/0213,271 Compositions and Methods For Modulating Dopamine NerutransmissionAbandonedMay 05, 06Sep 04, 08[A61K, C07H, C12Q, G01N, A61P, C07K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
